227 related articles for article (PubMed ID: 10605542)
1. Pantoprazole, Prout and the proton pump.
Playford RJ; Podas T; Modlin I
Hosp Med; 1999 Jul; 60(7):500-4. PubMed ID: 10605542
[TBL] [Abstract][Full Text] [Related]
2. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
Cheer SM; Prakash A; Faulds D; Lamb HM
Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
4. Triple therapy as a cure for Helicobacter pylori infection.
Bardhan KD
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S27-30. PubMed ID: 8930577
[TBL] [Abstract][Full Text] [Related]
5. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
Fitton A; Wiseman L
Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
[TBL] [Abstract][Full Text] [Related]
6. Proton-pump inhibitors: three of a kind?
Bateman DN
Lancet; 1997 Jun; 349(9066):1637-8. PubMed ID: 9186377
[No Abstract] [Full Text] [Related]
7. Review article: rabeprazole-based therapy in Helicobacter pylori eradication.
Barth J; Hahne W
Aliment Pharmacol Ther; 2002 Mar; 16 Suppl 1():31-3. PubMed ID: 11849125
[TBL] [Abstract][Full Text] [Related]
8. [2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].
Leonhardt U; Ritzel U; Ramadori G
Internist (Berl); 1996 Sep; 37(9):944-9; discussion 949. PubMed ID: 8964694
[No Abstract] [Full Text] [Related]
9. An overview of proton pump inhibitors.
Der G
Gastroenterol Nurs; 2003; 26(5):182-90. PubMed ID: 14603076
[TBL] [Abstract][Full Text] [Related]
10. [Antisecretor treatment of digestive hemorrhage associated to peptic ulcer: an approximation to the available evidence].
Bustamante Baléna M; Ponce García J
Rev Clin Esp; 2004 Mar; 204(3):161-8. PubMed ID: 15025985
[No Abstract] [Full Text] [Related]
11. [Pantoprazole. A new acid pump inhibitor against peptic ulcer and reflux esophagitis].
Wilson BV; Knudsen T
Ugeskr Laeger; 1996 Mar; 158(12):1695-7. PubMed ID: 8644421
[No Abstract] [Full Text] [Related]
12. Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
Adamek RJ; Behrendt J; Wenzel C
Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):811-7. PubMed ID: 11474311
[TBL] [Abstract][Full Text] [Related]
13. [Proton pump inhibitors in pediatrics].
Faure C; Pelatan C; Languepin J
Arch Pediatr; 1999 Jun; 6(6):650-6. PubMed ID: 10394458
[TBL] [Abstract][Full Text] [Related]
14. Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.
Meyer UA
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S21-5. PubMed ID: 8930576
[TBL] [Abstract][Full Text] [Related]
15. Pantoprazole, a new proton-pump inhibitor, has a precise and predictable profile of activity.
Parsons ME
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S15-20. PubMed ID: 8930575
[TBL] [Abstract][Full Text] [Related]
16. Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis.
Netzer P; Gut A; Brundler R; Gaia C; Halter F; Inauen W
Aliment Pharmacol Ther; 2001 Sep; 15(9):1375-84. PubMed ID: 11552908
[TBL] [Abstract][Full Text] [Related]
17. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
[TBL] [Abstract][Full Text] [Related]
18. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
[TBL] [Abstract][Full Text] [Related]
19. The changing role of H2-receptor antagonists in acid-related diseases.
Lamers CB
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
[TBL] [Abstract][Full Text] [Related]
20. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
Metz DC
Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
